Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Some drugs may help treat both COVID-19 and radiation injury.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Black henna tattoos can cause severe allergies to hair and textile dyes, and there's a need for greater public awareness and regulation.

Many people had severe allergic reactions to a common hair dye ingredient, causing them to seek medical care and miss work.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

The document explains how to do skin procedures, care after surgery, and when to use certain treatments.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Korean Red Ginseng may improve skin condition and reduce allergy markers in atopic dermatitis patients.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Remove inflamed cysts surgically, avoid topical antibiotics on wounds, treat skin and mouth conditions with specific medications, and address underlying causes of hair loss.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.